Matches in Nanopublications for { ?s ?p "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP189269.RAR9GA3km2cJGIkm9AGOYrBeWGJoCg0CR738K8C1qM3sI130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189269.RAR9GA3km2cJGIkm9AGOYrBeWGJoCg0CR738K8C1qM3sI130_provenance.
- NP800682.RAZDzorCK7UY7LQIjeFoVK9WBdf5vZCyhdg76RLUz5uTw130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800682.RAZDzorCK7UY7LQIjeFoVK9WBdf5vZCyhdg76RLUz5uTw130_provenance.
- NP684883.RASkzrqcX3xwzHei5oP4o_-uHfFPH1gmXF5xW0AxoNtj8130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684883.RASkzrqcX3xwzHei5oP4o_-uHfFPH1gmXF5xW0AxoNtj8130_provenance.
- assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP941243.RAS9bPyNvXBsnWbry1krtZWJyxp26_QQ0lhEO7X8QX7kk130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941243.RAS9bPyNvXBsnWbry1krtZWJyxp26_QQ0lhEO7X8QX7kk130_provenance.
- NP941244.RAvZdxP2OrtRC5y942o8_z7iZ7yBnyeYzjb6xBLCHBuKQ130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941244.RAvZdxP2OrtRC5y942o8_z7iZ7yBnyeYzjb6xBLCHBuKQ130_provenance.
- NP593889.RA9GrdSZyEuZK7AI-9lJ26pngnmtsu6j0ojEd_yMu4eV0130_assertion description "[Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593889.RA9GrdSZyEuZK7AI-9lJ26pngnmtsu6j0ojEd_yMu4eV0130_provenance.